Skip to main content
  • THRIVE

    In this study, satralizumab will be administered to see whether satralizumab is safe in patients with a burst brain aneurysm and if it may prevent strokes in patients with a burst brain aneurysm.

    Investigator
    Brian L Hoh
    Ages
    18 Years - 89 Years
    Sexes
    All